Virtus Fund Advisers’s Eastman Chemical EMN Stock Holding History

Virtus Fund Advisers’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-173	Closed	-$13K	–	935
2014 Q4	$13K	Sell	173 -4,779	-97%	-$378K	﹤0.01%	997
2014 Q3	$401K	Sell	4,952 -1,359	-22%	-$113K	﹤0.01%	434
2014 Q2	$551K	Buy	+6,311	New	+$548K	﹤0.01%	626

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtus Fund Advisers's EMN Position: Q1 2015 in Review

Virtus Fund Advisers sold out of Eastman Chemical (EMN) in Q1 2015, closing a stake of 173 shares — an estimated $13K sold.

Virtus Fund Advisers first reported a position in EMN in Q2 2014 and held it in 3 quarters. The position peaked at $551K in Q2 2014. 559 funds tracked by Wall St. Rank hold EMN as of Q1 2015.

Virtus Fund Advisers reported no remaining Eastman Chemical position as of Q1 2015 after selling out during the quarter.
Virtus Fund Advisers sold 173 Eastman Chemical shares in Q1 2015, an estimated $13K.
Virtus Fund Advisers first reported a position in Eastman Chemical in Q2 2014 and held it in 3 quarters.
Virtus Fund Advisers's Eastman Chemical position peaked at $551K in Q2 2014.
559 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2015.

Based on Virtus Fund Advisers's 13F filing for Q1 2015, filed 13 May 2015.